Matinas BioPharma
MTNB
#10151
Rank
ยฃ2.14 M
Marketcap
ยฃ0.42
Share price
1.90%
Change (1 day)
-94.70%
Change (1 year)

Earnings for Matinas BioPharma (MTNB)

Earnings in 2024 (TTM): -ยฃ16.5 Million

According to Matinas BioPharma's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -ยฃ18.28 Million a decrease over its 2022 earnings that were of -ยฃ16.73 Million. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Matinas BioPharma from 2013 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -ยฃ16.5 Million-9.73%
2023 -ยฃ18.28 Million9.26%
2022 -ยฃ16.73 Million-9.82%
2021 -ยฃ18.55 Million3.73%
2020 -ยฃ17.89 Million29.21%
2019 -ยฃ13.84 Million19.07%
2018 -ยฃ11.63 Million-7.91%
2017 -ยฃ12.63 Million108.5%
2016 -ยฃ6.06 Million-16.82%
2015 -ยฃ7.28 Million-10.62%
2014 -ยฃ8.15 Million175.27%
2013 -ยฃ2.96 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-ยฃ0.11 Billion 537.67%๐Ÿ‡บ๐Ÿ‡ธ USA